Gene polymorphisms and susceptibility to psychopathology in patients with metastatic carcinoid disease

Recruiting

• Conditions: carcinoid tumor; 10014713; 10037173

• Registration Number: NL-OMON30789
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

Patients with a proven carcinoïd syndrome, in who plasma tryptophan and urinary 5-HIAA levels are recently determined

Exclusion Criteria

Patients who, after being informed about the study, are not willing to participate.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- Biochemical data serotonin metabolism<br /><br>- Gene polymorphisms<br /><br>- Outcome questionnaires<br /><br><br /><br>Primary outcome: the relationship between certain gene polymorphisms and<br /><br>psychiatric symptomatology.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>no</p><br>